Dermatology
| Psoriasis
Dermatology
Psoriasis

PsoBest: Current status, profiles, impact for health care of the erman National Registry on Psoriasis

book_2 Source: EADV Virtual - Poster session
calendar_today Published on Medfyle: November 2020
headphones 2 min

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Key messages

  • PsoBest is a non-intervention registry that aims to collect long-term evidence of the safety and effectiveness of systemic therapies for psoriasis.
  • Over the past 12 years, 14,177 patients have been included, with 7,854 patient-years of biologic treatment and 9,147 on other treatments.
  • The most common biologics prescribed are adalimumab and ustekinumab.
  • The most common conventional systemics are fumaric acid esters and methotrexate.
Presenting Author
Read more arrow_downward Hide arrow_upward

Laura Kühl
Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Germany


Feedback